CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Application of Chimeric Antigen Receptor Modified γδ T Cells（CAR - γ δ T Cells） in Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04702841
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:16.761862+00:00
Published At: 2021-03-08T00:00:00+00:00
Record Updated At: 2021-03-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["CAR", "Malignant Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-03-08"
protocolSection.identificationModule.nctId: "NCT04702841"
protocolSection.identificationModule.officialTitle: "Clinical Application of Chimeric Antigen Receptor Modified \u03b3\u03b4 T Cells\uff08CAR - \u03b3 \u03b4 T Cells\uff09 in Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.